Hereditary Factor X Deficiency (HFXD) Survey shows unmet need in patients with rare bleeding disorder

/PRNewswire/ -- Bio Products Laboratory USA (BPL), a leading manufacturer of plasma-derived protein therapies, today presented initial data from the Hereditary...

Related Keywords

United States ,Houston ,Texas ,United Kingdom ,Elstree ,Hertfordshire ,Chicago ,Illinois ,America ,Eric Wolford ,Brian Branchford ,Hemophilia Treatment Centers Htcs ,College Of Wisconsin ,Bio Products Laboratory ,Versiti Medical Sciences Institute ,Scientific Advisory Council ,Prnewswire Bio Products Laboratory United States ,National Hemophilia Foundation ,Versiti Blood Research Institute ,Bio Products Laboratory United States ,Hemostasis Summit ,Products Laboratory United States ,Hereditary Factorx Deficiency ,America Survey ,North America ,Associate Medical Director ,Associate Investigator ,Associate Professor ,Medical College ,Hemophilia Treatment Centers ,Vice President ,Global Medical ,Annual Bleeding Disorders Conference ,Hemophilia Foundation Medical ,Concerning Products Licensed ,National Hemophilia ,Accessed August ,Products Laboratory United ,